Relevance of Reversible Causes During OHCA (Rebecca Study)

Status: Recruiting
Location: See all (2) locations...
Intervention Type: Diagnostic test
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Management of the reversible causes in cardiac arrest is fundamental for successful treatment of out-of-hospital cardiac arrests. Point-of-care diagnostics as prehospital emergency ultrasound, blood gas analysis and toxicological screening support the diagnostic process of evaluating potential reversible causes. Digital tools provide support of a structured approach. This study aims to evaluate the frequency of reversible causes during OHCA as well as specific interventions due to these findings. Furthermore, CPR performance (hands-off, ROSC, 30-day mortality) and cognitive load of the prehospital emergency physician will be investigated. In total 100 patients with OHCA will be included in this study. Identification of reversible causes will be performed upon a structured protocol using an interactive checklist. Cognitive load of emergency physician as well as CPR parameter (frequency of reversible causes, hands-off, ROSC, 30-day mortality) will be analysed.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Patients with prehospital cardiac arrest, where POCUS, blood gas analysis as well as screening for intoxication can integrated in ALS rhythm without delay of life-saving treatment or transportation will be included.

Locations
Other Locations
Austria
Anesthesiology and Intensive Care Medicine Department - Medical University of Vienna
NOT_YET_RECRUITING
Vienna
Department of Anesthesia, General Intensive Care and Pain Management,Medical University of Vienna
RECRUITING
Vienna
Contact Information
Primary
Andreas Schmid, Dr.
andreas.a.schmid@meduniwien.ac.at
014040024680
Backup
Christina Hafner, DDr.
christina.hafner@meduniwien.ac.at
Time Frame
Start Date: 2023-04-01
Estimated Completion Date: 2025-12-31
Participants
Target number of participants: 100
Treatments
Other: Evaluation of reversible causes using digital checklist and diagnostic support
Related Therapeutic Areas
Sponsors
Leads: Medical University of Vienna
Collaborators: Ludwig Boltzmann Institute for Digital Health and Prevention, Seibersdorf Labor GmbH

This content was sourced from clinicaltrials.gov